Featured Research

from universities, journals, and other organizations

New tool advances investigations of disease outbreaks

Date:
April 15, 2014
Source:
Molecular Biology and Evolution (Oxford University Press)
Summary:
A new field called genomic epidemiology is taking advantage of the rapidly reduced costs of next-generation DNA sequencing to better inform public health officials faced with ongoing outbreaks. While the authors caution that genomics alone cannot truly replace traditional epidemiology, they show the value and potential of using their sequence data analysis tool as a companion method for public health officials to shed light on outbreaks.

To combat disease outbreaks, public health officials often use painstaking fieldwork to try to stay one step ahead of the infectious bugs, linking patients' symptoms to a source of infection to quickly identify the common culprit in related cases.

Now, a new field called genomic epidemiology is taking advantage of the rapidly reduced costs of next-generation DNA sequencing to better inform public health officials faced with ongoing outbreaks. In the advanced online edition of Molecular Biology and Evolution, authors Didelot et al. developed a versatile computational tool that can rely on genomic data alone or be customized to add weighted information from field epidemiology (such as timing of infectivity, level of infectivity, geographic location, etc.). The research group tested the new tool's reliability against a real-world dataset to reconstruct the transmission of an outbreak of M. tuberculosis.

"We're on the edge of an exciting new era in public health epidemiology, as genomics gives us the ability to reconstruct outbreaks in far more detail and with much greater accuracy than ever before. This paper addresses an important question -- just how much information about an outbreak can we reliably derive from genomic data alone -- and gives public health officials a new tool for their detective kits," according to authors Jennifer Gardy, Caroline Colijn, and Xavier Didelot.

With their tool, they found that they were able to capture several aspects of known epidemiology. For example, their method correctly inferred the most likely source case and several key transmission clusters.

While the authors caution that genomics alone cannot truly replace traditional epidemiology, they show the value and potential of using their sequence data analysis tool as a companion method for public health officials to shed light on outbreaks.


Story Source:

The above story is based on materials provided by Molecular Biology and Evolution (Oxford University Press). Note: Materials may be edited for content and length.


Journal Reference:

  1. X. Didelot, J. Gardy, C. Colijn. Bayesian inference of infectious disease transmission from whole genome sequence data. Molecular Biology and Evolution, 2014; DOI: 10.1093/molbev/msu121

Cite This Page:

Molecular Biology and Evolution (Oxford University Press). "New tool advances investigations of disease outbreaks." ScienceDaily. ScienceDaily, 15 April 2014. <www.sciencedaily.com/releases/2014/04/140415181332.htm>.
Molecular Biology and Evolution (Oxford University Press). (2014, April 15). New tool advances investigations of disease outbreaks. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2014/04/140415181332.htm
Molecular Biology and Evolution (Oxford University Press). "New tool advances investigations of disease outbreaks." ScienceDaily. www.sciencedaily.com/releases/2014/04/140415181332.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins